You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 112 No. 8, August 1986 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Prognostic Significance of Thyroid Gland Involvement in Laryngeal Carcinoma

Ralph W. Gilbert, MD; Ron J. Cullen, MD; A. W. Peter van Nostrand, MD; Douglas P. Bryce, MD; Andrew R. Harwood, MD

Arch Otolaryngol Head Neck Surg. 1986;112(8):856-859.


Abstract

• We reviewed 173 laryngeal specimens that included thyroid tissue received from patients undergoing laryngectomy between 1966 and 1980 for evidence of thyroid gland invasion. Twenty-three (14%) of the larynges demonstrated thyroid involvement. In 15 specimens, involvement of the thyroid gland was by direct extension, and in eight the thyroid was involved metastatically. The survival in this group of patients was poor, with 18 patients dying of their disease within three years. Subglottic extension of 10 mm or greater was noted in 21 of 23 patients, and local recurrence was noted in 15 of 18 patients dying of their disease. The importance of removing one or both lobes of the thyroid gland in advanced laryngeal cancer is restated, and a surgically aggressive approach to the paratracheal nodes is recommended in patients with extensive subglottic involvement.

(Arch Otolaryngol Head Neck Surg 1986;112:856-859)



Author Affiliations

From the Departments of Otolaryngology (Drs Gilbert, van Nostrand, and Bryce) and Pathology (Dr van Nostrand), University of Toronto; the Royal Hospital, Wolverhampton, England (Dr Cullen); and the Department of Radiation Oncology, Princess Margaret Hospital, Toronto (Dr Harwood).


Footnotes

Accepted for publication Dec 2, 1985.

Read before the Fifth Joint Meeting of the American Society for Head and Neck Surgery and the Society of Head and Neck Surgeons, San Juan, Puerto Rico, May 5, 1985.

Reprint requests to Department of Pathology, Toronto General Hospital, 200 Elizabeth St EC3-301, Toronto, Ontario, Canada M5G 2C4 (Dr van Nostrand).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.